Single nucleotide polymorphismin RECQL and survival in resectable pancreatic adenocarcinoma

HPB

Volumn 11, Issue 5, 2009, Pages 435-444

  Cotton, Ronald T ^a   Li, Donghui ^b   Scherer, Steven E ^a   Muzny, Donna M ^a   Hodges, Sally E ^a   Catania, Robbi L ^a   Witkiewicz, Agniezka K ^c   Brody, Jonathan R ^c   Kennedy, Eugene P ^c   Yeo, Charles J ^c   Brunicardl, F Charles ^a   Gibbs, Richard G ^a   Gingras, Marie Claude ^a   Fisher, William E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Neoadjuvant and adjuvant therapy; Polymorphism; RECQ1; RECQL; Resectable pancreatic adenocarcinoma

Indexed keywords

ALANINE; CYSTEINE; RECQ HELICASE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR VOLUME;

EID: 70349528177     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00089.x     Document Type: Article

References (23)

1. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ et al. (eds) (2008) SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute. Based on November 2007 SEER data submission, posted to the SEER web site. http://seer.cancer.gov/csr/1975_2005 [Accessed 19 June 2009].
2. Yeo TP, Hruban RH, Leach SD, Wilentz RE, Sohn TA, Kern SE et al. (2002) Pancreatic cancer. Curr Probl Cancer 26:176-275.
3. Huang P, Chubb S, Hertel LW, Grindey GB, Plunkett W. (1991) Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Res 51:6110-6117.
4. Robinson BW, Im MM, Ljungman M, Praz F, Shewach DS. (2003) Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells. Cancer Res 63:6935-6941.
5. Sharma S, Doherty KM, Brosh RM. (2006) Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability. Biochem J 398:319-337.
6. Bohr VA. (2008) Rising from the RecQ-age: the role of human RecQ helicases in genome maintenance. Trends Biochem Sci 33:609-620.
7. Sharma S, Sommers JA, Choudhary S, Faulkner JK, Cui S, Andreoli L et al. (2005) Biochemical analysis of the DNA unwinding and strand annealing activities catalyzed by human RECQ1. J Biol Chem 280: 28072-228084.
8. Muzzolini L, Beuron F, Patwardhan A, Popuri V, Cui S, Niccolini B et al. (2007) Different quaternary structures of human RECQ1 are associated with its dual enzymatic activity. PLoS Biol 5:e20.
9. Popuri V, Bachrati CZ, Muzzolini L, Mosedale G, Costantini S, Giacomini E et al. (2008) The human RecQ helicases, BLM and RECQ1, display distinct DNA substrate specificities. J Biol Chem 288:17766-17776.
10. Bugreev DV, Brosh RM, Mazin AV. (2008) RECQ1 possesses DNA branch migration activity. J Biol Chem 283:20231-20242.
11. Sharma S, Brosh RM. (2008) Unique and important consequences of RECQ1 deficiency in mammalian cells. Cell Cycle 7:989-1000.
12. Doherty KM, Sharma S, Uzdilla LA, Wilson TM, Cui S, Vindigni A et al. (2005) RECQ1 helicase interacts with human mismatch repair factors that regulate genetic recombination. J Biol Chem 280:28085-28094.
13. Sharma S, Brosh RM. (2007) Human RECQ1 is a DNA damage responsive protein required for genotoxic stress resistance and suppression of sister chromatid exchanges. PLoS ONE 12:e1297.
14. Kawabe T, Tsuyama N, Kitao S, Nishikawa K, Shimamoto A, Shiratori M et al. (2000) Differential regulation of human RecQ family helicases in cell transformation and cell cycle. Oncogene 19:4764-4772.
15. Futami K, Kumagai E, Makino H, Goto H, Takagi M, Shimamoto A et al. (2008) Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase. Cancer Sci 99: 71-80.
16. Li D, Frazier M, Evans DB, Hess KR, Crane CH, Jiao L et al. (2006) Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. J Clin Oncol 24:1720-1728.
17. Li D, Liu H, Jiao L, Chang DZ, Beinart G, Wolff RA et al. (2006) Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. Cancer Res 66:3323-3330.
18. Ramensky V, Bork P, Sunyaev S. (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3892-3900.
19. Voidonikolas G, Kreml SS, Chen C, Fisher WE, Charles Brunicardi F, Gibbs RA et al. (2008) Basic principles and technologies for deciphering the genetic map of cancer. World J Surg 33:615-629.
20. Voidonikolas G, Gingras MC, Hodges S, McGuire AL, Chen C, Gibbs RA et al. (2009) Developing a tissue resource to characterize the genome of pancreatic cancer. World J Surg 33:723-731.
21. Zhang J, Wheeler DA, Yakub I, Wei S, Sood R, Rowe W et al. (2005) SNPdetector: a software tool for sensitive and accurate SNP detection. PLoS Comput Biol 1:e53.
22. Chen J, Li D, Killary AM, Sen S, Amos CL, Evans DB et al. (2009) Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. Ann Surg Oncol 16:431-439.
23. Brunicardi FC, Gibbs RA, Fisher W, Chen C. (2008) Overview of the molecular surgeon symposium on personalized genomic medicine and surgery. World J Surg 33:612-614.